SFP
GSK icon

Santa Fe Partners’s GSK GSK Stock Holding History

Santa Fe Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-23,751
Closed -$1.2M – 131
2015
Q4 		$1.2M Sell
23,751
-44,060
-65% -$2.25M 0.2% 191
2015
Q3 		$3.26M Buy
67,811
+29,481
+77% +$1.53M 0.43% 80
2015
Q2 		$2M Buy
38,330
+7,069
+23% +$398K 0.27% 142
2015
Q1 		$1.8M Buy
31,261
+4,909
+19% +$281K 0.22% 207
2014
Q4 		$1.41M Buy
26,352
+1,222
+5% +$68.4K 0.18% 239
2014
Q3 		$1.45M Buy
25,130
+21,696
+632% +$1.33M 0.22% 172
2014
Q2 		$230K Sell
3,434
-16,836
-83% -$1.14M 0.03% 454
2014
Q1 		$1.35M Sell
20,270
-25,512
-56% -$1.72M 0.19% 218
2013
Q4 		$3.06M Buy
45,782
+15,794
+53% +$1.02M 0.5% 34
2013
Q3 		$1.88M Buy
29,988
+23,037
+331% +$1.48M 0.36% 115
2013
Q2 		$434K Buy
+6,951
New +$441K 0.09% 350

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Santa Fe Partners's GSK Position: Q1 2016 in Review

Santa Fe Partners sold out of GSK (GSK) in Q1 2016, closing a stake of 23,751 shares — an estimated $1.2M sold.

Santa Fe Partners first reported a position in GSK in Q2 2013 and held it in 11 quarters. The position peaked at $3.26M in Q3 2015. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

  • Santa Fe Partners reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 23,751 GSK shares in Q1 2016, an estimated $1.2M.
  • Santa Fe Partners first reported a position in GSK in Q2 2013 and held it in 11 quarters.
  • Santa Fe Partners's GSK position peaked at $3.26M in Q3 2015.
  • 726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.